Economic aspects of chronic diseases in Vietnam by Van Minh, Hoang et al.
Economic aspects of chronic
diseases in Vietnam
Hoang Van Minh
1,*, Dao Lan Huong
2, Kim Bao Giang
1 and
Peter Byass
3
1Faculty of Public Health, Hanoi Medical University, Hanoi, Vietnam;
2World Bank Ofﬁce in Vietnam,
Hanoi, Vietnam;
3Umea ˚ Centre for Global Health Research, Umea ˚, Sweden
Introduction: There remains a lack of information on economic aspects of chronic diseases. This paper, by
gathering available and relevant research findings, aims to report and discuss current evidence on economic
aspects of chronic diseases in Vietnam.
Methods: Data used in this paper were obtained from various information sources: international and national
journal articles and studies, government documents and publications, web-based statistics and fact sheets.
Results: In Vietnam, chronic diseases were shown to be leading causes of deaths, accounting for 66% of all
deaths in 2002. The burdens caused by chronic disease morbidity and risk factors are also substantial. Poorer
people in Vietnam are more vulnerable to chronic diseases and their risk factors, other than being overweight.
The estimated economic loss caused by chronic diseases for Vietnam in 2005 was about US$20 million
(0.033% of annual national GDP). Chronic diseases were also shown to cause economic losses for families
and individuals in Vietnam. Both population-wide and high-risk individual interventions against chronic
disease were shown to be cost-effective in Vietnam.
Conclusion: Given the evidence from this study, actions to prevent chronic diseases in Vietnam are clearly
urgent. Further research findings are required to give greater insights into economic aspects of chronic
diseases in Vietnam.
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C
hronic diseases consist of a wide range of condi-
tions of long duration and generally slow pro-
gression. Chronic diseases are well known as
leading causes of mortality globally, representing 60%
of all deaths. Out of the 35 million people who died from
chronic diseases in 2005, more than 80% of these deaths
occurred in low and middle-income countries (1). The
number of deaths from chronic diseases will continue
increasing rapidly in the next decade and the low and
middle-income countries will carry the heaviest burden
(1, 2). Chronic diseases not only cause premature death,
but also have major adverse effects on the quality of life
of affected individuals and create large adverse economic
effects on families, communities and societies in general
(1). Four of the most prominent chronic diseases 
cardiovascular diseases, cancer, chronic obstructive pul-
monary disease and diabetes  are linked to modifiable
risk factors, notably high blood pressure, tobacco use,
alcohol drinking, unhealthy diets and physical inactivity.
Currently, the prevalence rates of these risk factors are
accelerating globally, especially in developing countries
(3, 4). Actions to prevent these major chronic diseases
should focus on controlling these and other key risk
factors in a well-integrated manner. As many chronic
disease interventions are effective and suitable for re-
source-constrained settings (1, 5), it is vitally important
that action against the impending chronic disease pan-
demic is taken urgently.
Vietnam is located in Southeast Asia and shares
borders with China to the north and Laos and Cambodia
to the west. The country covers an area of area of 331,000
km
2 and has a population of 85 million, with 50.8% of
the population estimated to be women and 49.2% men.
GDP per capita in Vietnam in 2007 was approximately
purchasing power parity dollars $3,000 (PPP) (6). Life
expectancy at birth (69 years for male and 74 years for
female in 2005) (7) and adult literacy rate (90.3% in 2004)
are high (8).
Like other developing countries, Vietnam is under-
going a rapid epidemiological transition resulting in an
increasing burden of chronic diseases. Chronic diseases
have been shown to be major causes of morbidity and
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admissions due to chronic diseases increased from 39% in
1986 to 68% in 2002 and chronic diseases deaths rose
from 42% in 1986 to 69% in 2002 (9). To respond to the
problems of chronic diseases, the Vietnamese Prime
Minister issued Decision No. 77/2002/QD-TTg on the
Ratification of the Programme of Prevention and Control
of Certain Non-Communicable Diseases for the period
20022010 (10). These documents highlight the impor-
tance of having comprehensive scientific evidence on
different aspect of chronic diseases, especially their socio-
economic patterning. This paper, by gathering available
relevant research findings, therefore aims to report and
discuss currently available evidence on economic aspects
of chronic diseases in Vietnam. The evidence on the
economic characteristics of this growing disease burden is
believed to be a firm background for justifying stronger
actions against chronic disease epidemics in Vietnam and
elsewhere.
Methods
Data used in this paper were obtained from the different
information sources: international and national journal
articles and studies, government documents and publica-
tions, web-based statistics and fact sheets. We used both
online and manual search methods to gather the infor-
mation.
The online search was performed in multiple electronic
bibliographic databases, including: Ovid MEDLINE,
PubMed and EMBASE. The following main key search
terms were used: chronic disease, non-communicable
disease, cardiovascular disease, cancer, diabetes or
chronic obstructive pulmonary disease) and economic,
cost, price, expenditure, expenses or spending and
Vietnam; hypertension, high blood pressure, tobacco
use, smoking, alcohol use, drinking, diet, overweight,
obesity or physical activity and economic, cost, price,
expenditure, expenses or spending and Vietnam. In
addition, search engines such as Google and Google
Scholar were also used.
Manual searches were done in the Vietnam National
Library as well as in libraries of different institutions,
such as the Ministry of Health, Hanoi Medical Uni-
versity, Hanoi School of Public Health, Health Strategy
and Policy Institute of Vietnam and other Non-Govern-
mental Organisations in Vietnam. Both English and
Vietnamese research reports conducted in Vietnam
within the last 10 years were included.
Results
Burden of chronic diseases and their related risk
factors in Vietnam
Table 1 presents the information on the burden of chronic
diseases and their related risk factors in Vietnam.
Chronic diseases were shown to be leading causes of
deaths. An estimate by WHO showed that, out of 516,000
deaths which occurred in 2002 in Vietnam, 341,000 (66%)
were attributable to chronic diseases (mainly ischaemic
heart disease, cerebrovascular disease and chronic ob-
structive pulmonary disease). The age-standardised mor-
tality rate from chronic diseases was 664.1 per 100,000
population (11).
The burden of morbidity from chronic diseases in
Vietnam was also substantial. According to national
statistics, from 1986 to 2003, the proportion of all
hospital admissions attributable to chronic diseases
increased from 39 to 68% (12, 13). Data from cancer
registries in Vietnam showed that, in 2000, the total
number of cancer cases in the whole country was 68,810
(36,024 men and 32,786 women). The crude prevalence of
cancer was 91.5 per 100,000 in men and 81.5 per 100,000
in women. These figures are similar to those in other
developing countries and lower than those of developed
countries (14). The National Diabetes Survey, conducted
in 2002, showed a prevalence of 2.7% for the whole
country, ranging from a lower rate of 2.1% in more
remote mountainous areas to 4.4% in the major cities.
The survey also revealed prevalence of impaired glucose
tolerance of 7.3%, indicating the potential for sharp
future increases in diabetes prevalence (15). A popula-
tion-based study in rural Vietnam found that 39% of
people aged 2574 years old reported at least one chronic
disease. More than 10% of them reported having two or
more chronic conditions (16).
Risk factors for chronic diseases were also common in
Vietnam. In 2002, 16.8% of Vietnamese aged 2564 years
old were shown to be afflicted by hypertension (17).
1 The
prevalence of cigarette smoking in men and women in
2002 was 56.1 and 1.8%, respectively (18). In 2004, data
from WHO showed that the prevalence of heavy and
hazardous alcohol drinking
2 among men and women was
5.7 and 0.6%, respectively (19). A recent study reported
that the prevalence of overweight in Vietnam has in-
creased sharply during 1992 and 2002 (from 2.0 to 5.7%).
Significant increases were observed for men and women,
in urban and rural areas, and for all age groups (20).
Economic determinants of chronic diseases and their
related risk factors in Vietnam
There are several methods for assessing economic status
of households in Vietnam, such as official economic
classification, household income, household expenditure,
housing condition and assets. The association between
1Hypertension was defined as systolic blood pressure (SBP) equal to
or more than 140 mmHg or diastolic blood pressure (DBP) equal to
or more than 90 mmHg or being treated for hypertension (I, IV).
2Heavy and hazardous alcohol drinking was defined as average
consumption of 40 g or more of pure alcohol a day for men and 20 g
or more of pure alcohol a day for women.
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(page number not for citation purpose)economic status and chronic disease mortality, morbidity
and risk factors has been examined in a few studies in
Vietnam.
Table 2 shows information on the economic determi-
nants of chronic diseases and their related risk factors in
Vietnam. Regarding mortality data, applying verbal
autopsy methods (21)
3 enabled the assessment of cause-
specific mortality (22). Minh et al. previously demon-
strated a possibly rising burden of mortality from
cardiovascular disease among the worse-off (23, 24).
4
This finding is contrary to the frequent supposition that
chronic diseases mainly affect rich people. International
literature has also shown that, in almost all countries, it is
the poorest people who are most at risk of developing
chronic diseases and dying prematurely from them (1).
Little research has been conducted in Vietnam on
associations between economic status and morbidity
from chronic diseases. In a study in rural Vietnam,
economic status was found to be inversely correlated
with the probability of having at least one chronic disease
among women only (i.e. the poorest women had a
significantly higher probability of having at least one
chronic disease than better-off women) (16). A complex
relationship between hypertension and economic status
was also revealed by other studies in the same study
setting, reporting that richer men and poorer women had
increased risks of being hypertensive as compared with
people of the same gender in the average living standard
group (25, 26). A relatively higher prevalence of self-
reported chronic disease and hypertension among poor
women could possibly be explained by Barker’s hypoth-
esis about infant origins of chronic adult diseases (2729).
In term of relationships between risk factors for
chronic diseases and economic status, findings from the
Vietnam National Health Survey in 2002 indicated that
tobacco smoking and alcohol drinking were more pre-
valent among the poor people than among the better-off
(10). Similarly, another Vietnamese research showed a
significantly lower risk of becoming a regular smoker and
the higher chance for cessation among the high-income
Table 1. Burden of chronic diseases and their related risk factors in Vietnam
Source Method used Data date Key findings
World Health Organization
(2002)
Modelling 2002 Number of deaths due to chronic diseases in 2002 was
341,000 (66% of total deaths). Age-standardised
mortality rate from chronic diseases was 664.1 per
100,000 population
Ministry of Health of Vietnam
(1987, 2003)
Hospital statistics 19962003 Proportion of all hospital admissions attributable to
chronic diseases increased from 39% in 1986 to 68%
in 2003
National Cancer Institute
(2008)
Registry 2000 Number of cancer cases in the whole country was 68,
810 (36,024 men, 32,786 women) Prevalence of cancer
was 91.5 per 100,000 in men and 81.5 per 100,000 in
women
Binh et al. (2002) Cross-sectional survey 2002 Prevalence of diabetes was 2.7% (all ages)
Cockram et al. (2006) Cross-sectional survey 2002 Prevalence of impaired glucose tolerance was 7.3%
(all ages)
Ministry of Health of
Vietnam (2003)
Cross-sectional survey 2002 Prevalence of hypertension among Vietnamese aged
2564 years old was 16.8%
Ministry of Health of
Vietnam (2003)
Cross-sectional survey 2003 Prevalence of cigarette smoking in 2002 was 56.1% in
men and 1.8% in women (aged 2564 years old)
World Health Organization
(2004)
Review 2004 Prevalence of heavy alcohol drinking was 5.7% in men
and 0.6% in women (aged 2564 years old)
Nguyen et al. (2007) Cross-sectional survey 19922002 Prevalence of overweight increased from 2.0% in 1992
to 5.7% in 2002 (all ages)
Minh et al. (2008) Cross-sectional survey 2005 Prevalence of self-reported chronic illness among
people aged 2574 years was 9%
3The method uses information obtained from close relatives or
caretakers of a deceased person about the circumstances, signs and
symptoms during the terminal illness in order to assign the most
likely cause of death.
4Economic status was assessed by local authorities based on income
per person per month. The poor were defined to have an average
income per person per month of less than 15 kg rice or about 3.3
USD (according to Decision number 59  Ministry of Labour,
Invalids and Social Affairs).
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(page number not for citation purpose)group compared to lower-income group (30). Some other
studies have shown that income appears to exert strong
effects on the decision to both initiate and to cease
smoking (31, 32).
A recent study by Nguyen et al. (20), based on three
national surveys of socio-economic factors and health
conducted over 10 years in Vietnam, reported higher rates
of overweight among people with higher incomes. How-
ever, this study also showed that as the national income
rose, higher rates ofoverweight began to be observed even
among lower-income women. These observations are
consistent with the international literature on obesity
and inequities in health in the developing world (33).
In summary, our available research findings illustrate
the fact that chronic diseases are no longer to be
considered as ‘diseases of affluence’. These results de-
monstrate the shift from ‘early to later adopter’ of
cardiovascular diseases (CVD) epidemic (34). Poorer
people in Vietnam are more vulnerable to chronic diseases
and their risk factors, except overweight. The poor are
more likely to be afflicted by chronic diseases because of
material deprivation and psychosocial stress, higher levels
of risky behaviour, unhealthy living conditions and
limited access to good-quality health care, etc. (1).
Economic costs of chronic diseases and their related
risk factors in Vietnam
Table 3 summarises research findings on the costs of
chronic diseases and their related risk factors in Vietnam.
Chronic diseases are a major cost and a profound
economic burden to societies. The macroeconomic costs
due to chronic diseases include direct costs (costs of
medical care in relation to prevention, diagnosis and
treatment of disease), indirect costs (loss of human
resources caused by morbidity or premature death) and
intangible costs (pain, stress, anxiety and suffering, etc.).
These costs are usually estimated using accounting or
cost-of-illness methods. The total cost is equal to the total
time lost through premature death and illness multiplied
by a wage rate, and sometimes accounting for unemploy-
ment. The sums of direct and indirect costs are then
assumed to amount to a loss of GDP (1).
Abegunde et al. (35), employing a modelling approach,
have estimated macroeconomic losses attributable to
coronary heart disease, stroke and diabetes in 23 coun-
tries in 2005. The estimated figure for Vietnam was about
US$20 million (accounting for 0.033% of annual national
GDP). The estimate would almost double by 2015 if no
intervention were made. The accumulated losses in GDP
due to chronic diseases in Vietnam between 2006 and
2015 could therefore be as much as US$270 million. The
figure for Vietnam was lower than that of other devel-
oping countries in the region like Indonesia (cumulative
losses of US$4.18 billion), Thailand (US$1.49 billion)
and the Philippines (US$620 million) (35). The modelling
approach might be expected to yield lower results then
the cost-of-illness method (35).
A recent empirical cost-of-illness study on the costs of
smoking in Vietnam reported that the total cost of
inpatient health care caused by smoking in Vietnam
reached at least as much as US$77.5 million in 2005.
This represents about 0.22% of Vietnam’s GDP and 4.3%
of total healthcare expenditure. The majority of these
expenses are related to chronic obstructive pulmonary
disease (COPD) treatment (US$68.9 million per year)
followed by lung cancer (US$5.2 million per year) and
Table 2. Economic determinants of chronic diseases and their related risk factors in Vietnam
Source Method used Data date Key findings
Minh et al. (2003, 2006) Longitudinal study 19992000
19992003
No significant difference in mortality rates from
cardiovascular disease by economic status
Minh et al. (2008) Cross-sectional survey 2005 The poorest women had a significantly higher
probability of having at least one chronic disease
than better-off women
Ministry of Health of
Vietnam (2003)
Cross-sectional survey 2002 Tobacco smoking and alcohol drinking were more
prevalent among the poor people than among the
better-off
Minh et al. (2005) Cross-sectional survey 2002 Significantly lower risk of becoming a regular
smoker and the higher chance for cessation among
the high-income group compared to lower-income
group
Anil et al. (2000) and
Bales et al. (2003)
Cross-sectional survey 2000 and 2002 Income appears to exert strong effect on the
decision to both initiate and to cease smoking
Nguyen et al. (2007) Cross-sectional survey 19922002 Higher rates of overweight among the higher-
income people
Hoang Van Minh et al.
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(page number not for citation purpose)ischemic disease (US$3.3 million per year). The govern-
ment directly finances about 51% of these costs. The rest is
financed either by households (34%) or by the insurance
sector (15%). The true costs would be substantially higher
if all smoking-related diseases, outpatient care and
mortality-related costs were included (36).
Chronic diseases were also shown to cause economic
losses for families and individuals in Vietnam. A study
from Northern Vietnam reported that 19% of rural
dwellers with diabetes had to sell assets, use savings or
borrow from neighbours to pay for health care costs (37).
Another study reported that household expenditures on
treatment of chronic disease illness were also considerable
and even reached ‘catastrophic’ levels (38).
5 Wagstaff
found that Vietnamese households have not been able to
hold their food and non-food consumption constant in
the face of income reduction and extra medical care
expenditure due to chronic illness (39).
Consumption of tobacco and alcohol, two established
chronic disease risk factors, were also shown to have
negative impacts on Vietnamese households’ economies.
Vietnam Living Standard Surveys found that, on average,
the expenditure on smoking and drinking of a household
in Vietnam made up 34% of total recurrent expenditure
of that household (i.e. expenditures on food, electricity,
water, telephone, fuel, health care and education) (4042).
Kinh et al. found that the tobacco spending of low-
income households represents a larger proportion of their
expenditure than for higher-income households. Low-
income households’ tobacco spending is equal to one-
and-a-half times their educational spending and is
equivalent to health care spending. By contrast, tobacco
expenditures for higher-income households are 46 and
69%, of educational and health expenditures, respectively
(43). Another household survey, conducted in five
provinces in Vietnam in 2003, reported an average annual
household expenditure on tobacco of US$39.8. The ratio
of tobacco spending to education expenditure was 228%
in the poorest households. The study also analysed the
influence of cigarette smoking on poverty by estimating
the potential reduction in the percentage of poor
households if money spent on tobacco was used instead
to buy food. According to this study, 11.3% of poor
households could escape from food poverty situations if
they spent their available money on food instead of on
tobacco (44).
Economic aspects of interventions against chronic
diseases
Table 4 presents evidence on the economic aspects of
interventions against chronic diseases. Available evidence
Table 3. Economic costs of chronic diseases and their related risk factors in Vietnam
Source Method used Data date Key findings
Abegunde et al. (2007) Modelling 2005 Losses because of coronary heart disease, stroke and diabetes were
about US$20 million (0.033% of annual national GDP). This figure would almost
doubled by 2015. The accumulated losses in GDP due to chronic diseases
in Vietnam between 2006 and 2015 could be as much as US$270 million
Ross et al. (2007) Cross-sectional
survey
2005 Cost of inpatient health care caused by smoking was US$77.5 million
(0.22% of Vietnam GDP and 4.3% of total healthcare expenditure) including
COPD treatment (US$68.9 million per year), lung cancer (US$5.2 million per
year) and ischaemic disease (US$3.3 million per year)
Hien (2004) Cross-sectional
survey
2003 19% of rural dwellers with diabetes had to sell assets, using savings or
borrowing from neighbours to pay for health care costs
Thuan et al. (2006) Longitudinal
study
2003 Household expenditures on treatment of chronic disease illness were also
considerable and even reached ‘catastrophic’ levels
Wagstaff et al. (2007) Cross-sectional
survey
2002 Vietnamese households have not been able to hold their food and non-food
consumption constant in the face of income reductions
and extra medical care spending because of chronic illness
General Statistics
Office of Vietnam (2006)
Cross-sectional
survey
2004 The expenditure on smoking and drinking of a household
in Vietnam made up 34% of total recurrent expenditure of that household
Van Kinh et al. (2006) Cross-sectional
survey
2002 Tobacco spending of low-income households represents a
larger proportion of their expenditure than for higher-income households
Hoang M et al. (2004) Cross-sectional
survey
2003 Average annual household expenditure on tobacco of US$39.8.The ratio of
tobacco spending to education expenditure was 228% in the poorest
households. 11.3% of poor households would escaped from food poverty
situation if they had spent their available money on food instead of on tobacco
5Catastrophic spending occurs when health care expenditure for a
household exceeds 40% of the households’ capacity to pay.
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tions against chronic diseases (1, 34, 45, 46). However,
little is known about the effects and cost-effectiveness of
different types of interventions against chronic diseases in
Vietnam. Recent work by Levy et al. (47), using the
SimSmoke model, showed that the overall effect of a
combination of policies, representing a 100% tobacco tax
increase; comprehensive workplace and restaurant smok-
ing bans with enforcement and publicity; a high-intensity
media campaign; higher enforcement and publicity for
the total ban on cigarette advertising and strong health
warnings; and strict youth access controls would result in
a reduction in smoking of about 29.6% in males and
22.4% in females in the immediate future. By 2033,
smoking prevalence is projected to drop by 38.5% for
males and 31.8% for females. Between 231,500 and
325,000 lives would be saved by 2033.
Asaria et al. (48), using a modelling approach, have
provided estimates on cost-effectiveness of two popula-
tion-wide interventions (reducing salt intake and imple-
menting four key elements of the WHO Framework
Convention on Tobacco Control) in 23 countries. The
intervention strategies would be cost-effective and have
substantial impacts in reducing the burden of chronic
diseases. For Vietnam, during 20062015, expected
deaths averted, as a result of these two interventions,
would be about 4080 per 100,000 populations older than
30 years. Total expenditure for implementing the salt
intervention, tobacco interventions,
6 and combination of
the two approaches would be $0.04, $0.11, and $0.16 per
person per year, respectively. Total costs of the two
interventions would therefore account for about 0.5% of
government health spending. According to this study, the
implementation of these interventions would be more
cost-effective in Vietnam than in other neighbouring
countries like China (the corresponding figures are $0.05,
$0.14 and $0.20, respectively), the Philippines ($0.05,
$0.13 and $0.18) and Thailand ($0.06, $0.17 and $0.23)
(48).
Information on the cost-effectiveness of preventing
cardiovascular diseases in high-risk individuals have also
been shown in a simulation model by Lim et al. (49). The
exercise showed that treatment of high-risk individuals
with aspirin, blood pressure-lowering drugs and choles-
terol-lowering drugs, to prevent cardiovascular disease,
would be effective and cost-effective in developing
countries. For Vietnam, a programme scaled-up up to
the target coverage of 80% would be estimated to avert
266,000 deaths over the period 20062015. The average
cost per treated individual per year would be $0.66. This
cost includes resources for drugs, health service delivery,
screening and treatment, laboratories, administration,
monitoring and assessment of the programme. This
high-risk individual intervention was shown to be poten-
tially more cost-effective in Vietnam than in other
neighbouring countries like Thailand and Indonesia (49).
In 2005, to encourage action for preventing chronic
diseases, WHO proposed a global goal of a 2% yearly
decrease in projected age-specific death rates from
chronic diseases worldwide (2). In Vietnam, achievement
of the global goal would result in additional gains in
healthy life expectancy of 1.7 years and in healthy life
expectancy of 1.5 years (18).
Discussion
We have shown that, at current stage of epidemiological
transition, Vietnam is heavily burdened by chronic
diseases, epidemiologically and economically. Existing
Table 4. Economic aspects of interventions against chronic diseases
Source Method used Key findings
Levy et al. (2006) Modelling The effect of a combination of policies (100% tobacco tax increase; comprehensive worksite
and restaurant smoking bans with enforcement and publicity; a high-intensity media
campaign; higher enforcement and publicity of the total ban on cigarette advertisements and
strong health warnings; and strict youth access controls) would result in a reduction in smoking
of about 29.6% in males and 22.4% in females in the immediate future
Asaria et al. (2007) Modelling Reducing salt intake and implementing 4 key elements of the WHO Framework Convention on
Tobacco Control would reduce 4080 deaths per 100,000 populations older than 30 years. The
cost of the two approaches separately and combined would be $0.04, $0.11 and $0.16 per
person per year, respectively
Lim et al. (2007) Modelling Treatment of high-risk individuals with aspirin, blood pressure-lowering drugs and cholesterol-
lowering drugs would be estimated to avert 266,000 deaths over the period 20062015. The
average cost per treated individual per year would be $0.60
6Tobacco interventions include: increased taxes on tobacco
products; enforcement of smoke-free workplaces; requirements for
FCTC-compliant packaging and labelling of tobacco products
combined with public awareness campaigns about the health risks
of smoking; and a comprehensive ban on tobacco advertising,
promotion and sponsorship.
Hoang Van Minh et al.
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diseases are feasible and cost-effective in Vietnam. Given
the evidence from this study, interventions against chronic
diseases in Vietnam should be comprehensive and inte-
grated, including both primary and secondary ap-
proaches, as well as policy-level involvements. Primary
prevention towards increasing the population proportion
at low riskof developing chronic diseases (i.e. population-
wide approach to reduce salt intake and tobacco use)
should be a priority. The aim should be to make small
improvements in a large proportion of the population.
Secondary prevention for early treatment of individuals
with established chronic diseases is also an important
component. This will help to reduce complication rates
and improvetheirqualityof life. Cost-effective medication
(aspirin, low-cost diuretics and beta-blockers, etc.) need
to be available for use at all health care levels (50).
Policy-level interventions have a crucial role in the
prevention and control of chronic diseases in any country.
In Vietnam, concrete policy frameworks should be put in
place to strengthen the National Programme of Preven-
tion and Control of Certain Non-communicable Diseases.
The programme should be integrated into the primary
health care system and other existing well-established
health programmes such as the Primary Health Care
Programme and Nutrition Programme, etc. This will help
reduce costs of prevention as well as taking full advantage
of existing capacity. Importantly, central and local Gov-
ernments and Health Authorities should provide timely
special protection for vulnerable groups. These include
children, women, less educated people and the poor, who
usually have limited choices about the food they eat, their
living conditions, and access to education and health care.
There is also a need to increase the share of financial
resources allocated to prevention, which is currently very
limited. The FrameworkConvention on Tobacco Control,
whichwasratifiedinVietnam,shouldbefurtherpromoted
by passing laws against smoking.
This is a preliminary review of economic aspects of
chronic diseases in Vietnam. The evidence documented in
this paper may not yet be compelling. Further empirical
research findings are required to give greater insights into
the issues.
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